The D3-receptor agonist (±)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice

This publication has 17 references indexed in Scilit:

• Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line
  European Journal of Pharmacology: Molecular Pharmacology, 1994
• Dopamine receptor pharmacology
  Trends in Pharmacological Sciences, 1994
• The role of dopamine D1-receptors in morphine-induced hyperlocomotion in mice
  Neuroscience Letters, 1994
• Blockade of the morphine-induced increase in turnover of dopamine on the mesolimbic dopaminergic system by κ -opioid receptor activation in mice
  Life Sciences, 1993
• Pharmacological aspects of R-( + )-7-OH-DPAT, a putative dopamine D3 receptor ligand
  European Journal of Pharmacology, 1993
• Modification of morphine-induced locomotor activity by pertussis toxin: biochemical and behavioral studies in mice
  Brain Research, 1993
• Modulation of Cocaine Self-Administration in the Rat Through D-3 Dopamine Receptors
  Science, 1993
• Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other “D-2-like” agonists
  Neuropharmacology, 1993
• Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin.
  Proceedings of the National Academy of Sciences, 1992
• Interactions between d-Ala-Met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat
  Behavioural Brain Research, 1980